Tore Bjerregaard Stage

Preventing chemotherapy-induced peripheral neuropathy

Applicant

Tore Bjerregaard Stage

Project description

Chemotherapy-induced peripheral neuropathy (CIPN) is a severe side effect provoked by several chemotherapeutics. CIPN causes less effective cancer treatment and pain for both cancer patients and cancer survivors. CIPN is caused by damage to pain-sensing neurons in the peripheral nervous system. We have developed a topical formulation of a well-known drug that will prevent the chemotherapy from damaging these cells and thus relieve symptoms among cancer patients. This will improve quality of life among cancer patients and survivors.

Institution

University of Southern Denmark